Viewing Study NCT02605967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-02-06 @ 6:07 AM
Study NCT ID: NCT02605967
Status: COMPLETED
Last Update Posted: 2022-02-10
First Post: 2015-10-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nasopharyngeal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PDR001 View
None nasopharyngeal cancer View
None moderately differentiated/undifferentiated View
None locally advanced View
None recurrent or metastatic NPC View
None after first- line platinum-based therapy View